In Texas, Glycos Biotechnologies it has created the first ever microbial platform for the efficient synthesis of biofuels and biochemicals from fatty acids. This revolutionary advancement builds on GlycosBio’s microorganism platform and further diversifies the set of feedstocks and co-products the company offers enabling greater cost savings and product flexibility for producers.
Glycos Biotechnologies, Inc., an emerging biochemical company leveraging metabolic and microbial engineering (earlier post), has developed what it says is the first microbial platform for the efficient synthesis of biofuels and biochemicals from fatty acids.
Asia’s robust manufacturing sector is luring Western biorefinery developers to the East, where myriad green chemicals are in high demand due to the growth of industry-and lack of red tape-in the region. Asian demand for acetic acid, for example, is expected to grow 8 to 9 percent per year, while U.S. demand for the product is expected to remain relatively flat. And that’s just a small part of the story.
It was no small feat getting common microbes to produce biochemicals from cheap, green and plentiful sources in the lab, but Houston-based Glycos Biotechnologies thinks it may have hit the jackpot by getting them to do it in a large scale, commercial-size facility.
Bio-XCell, a biotechnology eco-system and park to be built in Nusajaya, Iskandar Malaysia, welcomed its first three tenants yesterday after sealing memoranda of agreement (MoA) with the respective companies in deals valued at a collective RM300mil.
Texas-based Glycos Biotechnologies Inc. is expanding its biochemical production capabilities to Malaysia under an agreement with Malaysian Bio-XCell Sdn. Bhd., a government-supported industrial ecosystem focused on the advancement of biotechnology in the country.
Houston-based Glycos Biotechnologies announced today that it is building a biochemical plant as well as a biotech R&D facility in Malaysia under a collaboration with the country’s biotech hub Bio-XCell Sdn. Bhd., a government-supported industrial ecosystem focused on the advancement of biotechnology in Malaysia.
Glycos Biotechnologies Inc. has scored a deal with Bio-XCell Sdn. Bhd. that will expand GlycosBio’s presence into Malaysia.
Glycos Biotechnologies, Inc. (GlycosBio), a biochemical company using metabolic engineering and microbiology for the production of sustainable biochemicals, is expanding into Malaysia.
Glycos Biotechnologies (GlycosBio), a biochemical company focused on metabolic engineering and microbiology innovations for the production of sustainable biochemicals, inked an agreement with Bio-XCell for assistance with construction of its biochemical plant and biotechnology R&D facility within Bio-XCell’s industrial park in Malaysia.